Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APL180 in Healthy Volunteers and CHD Patients
NCT00568594Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2007
- Primary completion
- Sep 2009
- Modality
- Peptides, Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of APL180 in coronary heart disease (CHD), sponsored by Novartis. Started Nov 2007; status: completed.
02
Drugs
APL180
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00568594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568594.